| 86R6237 SCL-D  
---|---  
|  By: Davis of Harris | H.B. No. 1298  
---  
|  A BILL TO BE ENTITLED  
|  AN ACT  
| relating to prescription drug cost increases; imposing a civil  
| penalty.  
|  BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:  
|  SECTION 1. Subtitle A, Title 6, Health and Safety Code, is  
| amended by adding Chapter 441 to read as follows:  
| _CHAPTER 441. PRESCRIPTION DRUG COST TRANSPARENCY_  
| _SUBCHAPTER A. GENERAL PROVISIONS_  
|  _Sec. 441.0001. DEFINITIONS. In this chapter:_  
|  _(1)_ _____"Commission" means the Health and Human Services_  
| _Commission._  
|  _(2)_ _____"Health benefit plan issuer" means an insurer,_  
| _health maintenance organization, or other entity authorized to_  
| _provide health benefit coverage under the laws of this state._  
|  _(3)_ _____"Manufacturer" means a person engaged in the_  
| _business of producing, preparing, propagating, compounding,_  
| _converting, processing, packaging, labeling, or distributing a_  
| _prescription drug. The term does not include a wholesale_  
| _distributor or retailer of prescription drugs or a pharmacist_  
| _licensed under Subtitle J, Title 3, Occupations Code._  
|  _(4)_ _____"Prescription drug" has the meaning assigned by_  
| _Section 551.003, Occupations Code._  
|  _Sec._ ___441.0002._ _____REQUEST FOR INFORMATION. The commission or_  
| _attorney general may request information necessary to carry out the_  
| _purposes of this chapter from another state agency. A state agency_  
| _receiving a request under this section shall provide the requested_  
| _information in a reasonable time._  
| _SUBCHAPTER B. LISTS OF PRESCRIPTION DRUGS_  
|  _Sec._ ___441.0051._ _____COMMISSION LIST BY WHOLESALE ACQUISITION_  
| _COST. (a) The commission shall annually compile a list of_  
| _prescription drugs by wholesale acquisition cost._  
|  _(b) The list described by Subsection (a) must:_  
|  _(1) include 10 prescription drugs:_  
|  _(A)_ _____on which the commission or another state_  
| _agency spends a significant amount of money under a health benefit_  
| _plan administered by the agency; and_  
|  _(B)_ _____for which the wholesale acquisition cost has_  
| _increased by at least:_  
|  _(i)_ _____50 percent during the previous five_  
| _calendar years; or_  
|  _(ii)_ _____15 percent during the previous_  
| _calendar year;_  
|  _(2)_ _____include at least one generic and one brand name_  
| _drug;_  
|  _(3)_ _____indicate which drugs on the list are specialty_  
| _drugs;_  
|  _(4)_ _____include the percentage increase of the wholesale_  
| _acquisition cost for each drug on the list during the previous_  
| _calendar year and during the previous five calendar years;_  
|  _(5)_ _____rank the drugs on the list from those with the_  
| _largest increase in wholesale acquisition cost to those with the_  
| _smallest increase in wholesale acquisition cost based on the_  
| _previous calendar year;_  
|  _(6)_ _____state whether each drug on the list was included on_  
| _the list because of the wholesale acquisition cost increase over_  
| _the past five years or during the previous calendar year or both;_  
| _and_  
|  _(7)_ _____provide the state's total expenditure for each_  
| _drug on the list during the previous calendar year._  
|  _Sec._ ___441.0052._ _____COMMISSION LIST BY STATE COST. (a) In_  
| _addition to the list described by Section 441.0051, the commission_  
| _shall annually compile a list of prescription drugs by state cost._  
|  _(b) The list described by Subsection (a) must:_  
|  _(1) include 10 prescription drugs:_  
|  _(A)_ _____on which the commission or another state_  
| _agency spends a significant amount of money under a health benefit_  
| _plan administered by the agency; and_  
|  _(B)_ _____for which the cost to the agency, excluding_  
| _any rebate or other price concession, has increased by at least:_  
|  _(i)_ _____50 percent during the previous five_  
| _calendar years; or_  
|  _(ii)_ _____15 percent during the previous_  
| _calendar year;_  
|  _(2)_ _____include at least one generic and one brand name_  
| _drug;_  
|  _(3)_ _____indicate which drugs on the list are specialty_  
| _drugs;_  
|  _(4)_ _____rank the drugs on the list from those with the_  
| _largest increase in net cost to those with the smallest increase_  
| _based on the previous calendar year; and_  
|  _(5)_ _____state whether each drug on the list was included on_  
| _the list because of the cost increase over the past five years or_  
| _during the previous calendar year or both._  
|  _Sec._ ___441.0053._ _____MAJOR HEALTH BENEFIT PLAN ISSUER LIST;_  
| _REPORT. (a) This section applies only to a health benefit plan_  
| _issuer that is authorized to write a health benefit plan in this_  
| _state and that provides health benefit plan coverage for at least_  
| _5,000 enrollees._  
|  _(b)_ _____A health benefit plan issuer shall annually compile a_  
| _list of prescription drugs by cost._  
|  _(c) The list described by Subsection (b) must:_  
|  _(1) include 10 prescription drugs:_  
|  _(A)_ _____on which the health benefit plan issuer_  
| _spends a significant amount of money; and_  
|  _(B)_ _____for which the cost to the issuer's health_  
| _benefit plans, excluding any rebate or other price concession, has_  
| _increased by at least:_  
|  _(i)_ _____50 percent during the previous five_  
| _calendar years; or_  
|  _(ii)_ _____15 percent during the previous_  
| _calendar year;_  
|  _(2)_ _____include at least one generic and one brand name_  
| _drug;_  
|  _(3)_ _____indicate which drugs on the list are specialty_  
| _drugs;_  
|  _(4)_ _____rank the drugs on the list from those with the_  
| _largest increase in net cost to those with the smallest increase_  
| _based on the previous calendar year; and_  
|  _(5)_ _____state whether each drug on the list was included on_  
| _the list because of the cost increase over the past five years or_  
| _during the previous calendar year or both._  
|  _(d)_ _____A health benefit plan issuer shall provide to the_  
| _attorney general an annual written report on the list described by_  
| _Subsection (b) that states:_  
|  _(1)_ _____the percentage by which the net cost to the_  
| _issuer's health benefit plans has increased during the previous_  
| _calendar year and during the previous five calendar years for each_  
| _prescription drug on the list; and_  
|  _(2)_ _____the issuer's total expenditure, excluding any_  
| _rebate or other price concession, for each drug on the list during_  
| _the previous calendar year._  
|  _(e)_ _____Except as provided by Section 441.0054(b), information_  
| _provided to the attorney general under Subsection (d) is_  
| _confidential and excepted from disclosure under Chapter 552,_  
| _Government Code._  
|  _(f)_ _____The commissioner of insurance, in consultation with the_  
| _executive commissioner, may adopt rules necessary to implement this_  
| _section, including rules:_  
|  _(1)_ _____designating which prescription drugs are_  
| _considered to be specialty drugs for purposes of this chapter; and_  
|  _(2)_ _____governing the manner in which a health benefit_  
| _plan issuer identifies a drug as a specialty drug for purposes of_  
| _this chapter._  
|  _Sec._ ___441.0054._ _____REPORT TO ATTORNEY GENERAL. (a) Not later_  
| _than June 1 of each year, the commission and each health benefit_  
| _plan issuer to which Section 441.0053 applies shall provide each_  
| _list required under this subchapter to the attorney general._  
|  _(b)_ _____The attorney general and commission shall post the lists_  
| _described by Subsection (a) on the attorney general's and_  
| _commission's Internet websites._  
| _SUBCHAPTER C. PRICE JUSTIFICATION_  
|  _Sec._ ___441.0101._ _____ATTORNEY GENERAL LIST. (a) Using the lists_  
| _provided under Section 441.0054 and except as provided by_  
| _Subsection (b), the attorney general shall compile an aggregate_  
| _list of 15 prescription drugs for which the greatest amount of money_  
| _was spent across all payers during the previous calendar year._  
|  _(b)_ _____If fewer than 15 prescription drugs appear on more than_  
| _one payer's list, the attorney general shall rank the remaining_  
| _drugs based on the amount of money spent by any one payer during the_  
| _previous calendar year, in descending order, and may select as many_  
| _of the drugs based on that ranking as necessary to reach a total of_  
| _15 drugs required under Subsection (a)._  
|  _(c)_ _____The attorney general shall provide written notice to_  
| _each manufacturer of a prescription drug on the list described by_  
| _Subsection (a) of the drug's placement on the list and the_  
| _manufacturer's duties under this subchapter._  
|  _Sec._ ___441.0102._ _____PRICE JUSTIFICATION REQUIRED. (a) On_  
| _receipt of the notice described by Section 441.0101(c), a_  
| _manufacturer shall provide to the attorney general in the form and_  
| _manner prescribed by the attorney general a written report on the_  
| _prescription drug described by the notice._  
|  _(b) The report described by Subsection (a) must include:_  
|  _(1)_ _____a justification for the increase in the net cost of_  
| _the prescription drug for the commission, a health benefit plan_  
| _issuer, or both; and_  
|  _(2)_ _____all relevant information and supporting_  
| _documentation necessary to support the justification described by_  
| _Subdivision (1), including:_  
|  _(A)_ _____each factor that specifically caused the net_  
| _cost increase;_  
|  _(B)_ _____the percentage of the total cost increase_  
| _attributable to each factor; and_  
|  _(C)_ _____an explanation of the role of each factor in_  
| _contributing to the cost increase._  
|  _(c)_ _____A manufacturer shall provide the report described by_  
| _Subsection (a) in the form and manner prescribed by the attorney_  
| _general to the attorney general._  
|  _(d)_ _____A manufacturer shall provide additional information_  
| _concerning a listed prescription drug or a cost increase to the_  
| _attorney general on request by the attorney general._  
|  _(e)_ _____A manufacturer may request a portion of the information_  
| _provided to be excepted from publication and held as confidential_  
| _in accordance with Section 552.110, Government Code, or other_  
| _applicable law, and shall provide an explanation for each request_  
| _to the attorney general. If the attorney general finds that the_  
| _request is justified, the information shall:_  
|  _(1)_ _____be redacted from the report provided under this_  
| _section;_  
|  _(2) be confidential; and_  
|  _(3)_ _____be excepted from disclosure under Chapter 552,_  
| _Government Code._  
|  _(f)_ _____The attorney general may adopt rules necessary to_  
| _implement this section._  
|  _Sec._ ___441.0103._ _____ATTORNEY GENERAL REPORT TO LEGISLATURE. (a)_  
| _Not later than December 1 of each year, the attorney general shall_  
| _provide a written report to the legislature on the manufacturer_  
| _reports described by Section 441.0102 received by the attorney_  
| _general during the previous calendar year._  
|  _(b)_ _____The attorney general and commission shall post the_  
| _report described by Subsection (a) and each copy of a_  
| _manufacturer's report provided under Section 441.0102, redacted as_  
| _necessary, on the attorney general's and commission's Internet_  
| _websites. The attorney general and commission may inform the_  
| _public of the availability of the reports posted under this_  
| _subsection._  
|  _Sec._ ___441.0104._ _____CONSTRUCTION OF SUBCHAPTER. This subchapter_  
| _may not be construed to restrict the legal ability of a manufacturer_  
| _to increase prescription drug prices in accordance with federal_  
| _law._  
|  _Sec._ ___441.0105._ _____ENFORCEMENT. A manufacturer that violates_  
| _Section 441.0102 or a rule adopted under this chapter is liable to_  
| _the state for a civil penalty of not more than $10,000 for each_  
| _violation. Each failure to provide information to the attorney_  
| _general is a separate violation. The attorney general may bring_  
| _suit to provide for injunctive relief or to recover a civil penalty,_  
| _or both._ ___The attorney general may recover court costs and_  
| _reasonable attorney's fees._  
|  SECTION 2. As soon as practicable after the effective date  
| of this Act, the executive commissioner of the Health and Human  
| Services Commission shall identify, provide to the attorney  
| general, and post on the commission's Internet website the list of  
| prescription drugs and manufacturers required by Sections 441.0051  
| and 441.0052, Health and Safety Code, as added by this Act.  
|  SECTION 3. Notwithstanding Section 441.0103, Health and  
| Safety Code, as added by this Act, the attorney general is not  
| required to submit the initial report required by that section  
| before December 1, 2020.  
|  SECTION 4. This Act takes effect September 1, 2019.

